Ibuprofen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, backache, muscular aches, minor pain of arthritis, menstrual cramps, toothache, and discomfort related to the common cold. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be administered according to the following guidelines to ensure safety and efficacy.

For adults and children aged 12 years and older, the recommended dosage is 1 caplet every 4 to 6 hours as needed while symptoms persist. If pain or fever does not adequately respond to 1 caplet, a dose of 2 caplets may be taken. However, it is imperative that the total daily dosage does not exceed 6 caplets within a 24-hour period, unless otherwise directed by a healthcare professional.

For children under 12 years of age, it is advised to consult a doctor for appropriate dosing recommendations.

Healthcare professionals should emphasize the importance of using the smallest effective dose and adhering strictly to the prescribed dosage to avoid potential adverse effects.

Contraindications

Use is contraindicated in patients with a history of allergic reactions to ibuprofen or any other pain reliever or fever reducer, due to the potential for severe hypersensitivity reactions. Additionally, the use of this product is contraindicated in individuals who are undergoing heart surgery or have had heart surgery recently, as it may increase the risk of complications during the perioperative period.

Warnings and Precautions

Ibuprofen may elicit severe allergic reactions, particularly in individuals with a known allergy to aspirin. Symptoms indicative of an allergic response may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek medical assistance.

The use of this product, which contains a nonsteroidal anti-inflammatory drug (NSAID), carries a significant risk of severe stomach bleeding. This risk is notably elevated in patients who are 60 years of age or older, have a history of stomach ulcers or bleeding disorders, are concurrently using anticoagulants or steroid medications, are taking other NSAIDs (including aspirin, ibuprofen, or naproxen), consume three or more alcoholic beverages daily while using this product, or exceed the recommended dosage or duration of use.

Furthermore, NSAIDs, excluding aspirin, are associated with an increased risk of heart attack, heart failure, and stroke, which can be fatal. The likelihood of these serious cardiovascular events is heightened with the use of higher doses or prolonged treatment.

Healthcare professionals should advise patients to seek emergency medical help or contact a Poison Control Center (1-800-222-1222) immediately if they experience any of the following symptoms:

• Signs of stomach bleeding, including feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain.

• Symptoms suggestive of heart problems or stroke, such as chest pain, difficulty breathing, slurred speech, or weakness localized to one side of the body.

• Leg swelling.

• Worsening pain that persists beyond 10 days.

• Fever that worsens or lasts more than 3 days.

• Redness or swelling in the affected area.

• Any new or unexplained symptoms.

It is crucial for healthcare providers to monitor patients closely for these adverse effects and to educate them on the importance of adhering to recommended dosages and reporting any concerning symptoms promptly.

Side Effects

Patients using ibuprofen may experience a range of adverse reactions, which can be categorized by seriousness and frequency.

Serious adverse reactions include severe allergic reactions, particularly in individuals with a known allergy to aspirin. Symptoms of such reactions may manifest as hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, or blisters. In the event of an allergic reaction, patients are advised to discontinue use and seek immediate medical assistance.

Additionally, ibuprofen, as a nonsteroidal anti-inflammatory drug (NSAID), carries warnings regarding the risk of severe stomach bleeding. This risk is heightened in patients who are 60 years of age or older, have a history of stomach ulcers or bleeding problems, are taking anticoagulants or steroid medications, consume three or more alcoholic drinks daily, or exceed the recommended dosage or duration of use. Patients should be vigilant for signs of stomach bleeding, which include feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain.

The use of NSAIDs, excluding aspirin, is also associated with an increased risk of heart attack, heart failure, and stroke, which can be fatal. This risk escalates with prolonged use or higher than recommended dosages.

Common adverse reactions may include gastrointestinal discomfort, and patients should be advised to consult a healthcare provider if they experience worsening pain lasting more than 10 days, fever persisting beyond three days, or any new symptoms. Signs of heart problems or stroke, such as chest pain, difficulty breathing, slurred speech, or unilateral weakness, warrant immediate medical attention.

Patients are encouraged to seek medical advice before using ibuprofen if they have a history of serious side effects from pain relievers or fever reducers, or if they have conditions such as high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or a history of stroke. It is also important for patients taking aspirin for cardiovascular protection to consult a healthcare professional, as ibuprofen may diminish the cardioprotective effects of aspirin.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ibuprofen 200 mg. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 1 caplet every 4 to 6 hours as needed while symptoms persist. If pain or fever does not adequately respond to 1 caplet, 2 caplets may be administered. It is important not to exceed 6 caplets in a 24-hour period unless directed by a healthcare provider.

Geriatric Use

Elderly patients may have an increased risk of severe stomach bleeding, particularly those aged 60 years and older. Therefore, caution is advised when prescribing this medication to geriatric patients. It is recommended that the smallest effective dose be utilized in this population to minimize potential adverse effects.

In cases where stomach upset occurs, it is advisable for elderly patients to take the medication with food or milk to help alleviate gastrointestinal discomfort. Close monitoring of these patients is essential to ensure safety and efficacy while minimizing the risk of complications associated with treatment.

Pregnancy

Pregnant patients and women who are breastfeeding should consult a healthcare professional before using this medication. The use of ibuprofen is particularly cautioned against after 20 weeks of pregnancy, as it may pose risks to the developing fetus and lead to complications during delivery. Healthcare providers should carefully evaluate the necessity of ibuprofen in these patients, considering potential adverse fetal outcomes and the overall health of both the mother and the unborn child.

Lactation

Lactating mothers are advised to consult a healthcare professional before using this medication. It is particularly important to avoid the use of ibuprofen at 20 weeks of gestation or later unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data provided regarding the excretion of ibuprofen in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if they have a history of kidney disease. It is essential to assess the patient's overall health status, including any comorbid conditions such as high blood pressure, heart disease, liver cirrhosis, asthma, or a history of stroke, as these factors may influence the management of their renal function and the appropriateness of treatment. Monitoring and potential dosing adjustments may be necessary based on the patient's renal status to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment may experience altered pharmacokinetics of the medication due to compromised liver function. It is essential to assess the severity of liver impairment before initiating treatment.

For patients with liver cirrhosis, careful consideration should be given to dosage adjustments, as these individuals may require a reduced dose or an alternative therapy. Regular monitoring of liver function tests is recommended to evaluate the ongoing safety and efficacy of the treatment in this population.

Additionally, patients with a history of high blood pressure, heart disease, kidney disease, asthma, or stroke should be closely monitored for any potential interactions or exacerbations of their underlying conditions while receiving therapy.

Overall, a thorough evaluation of liver function and ongoing monitoring are critical for ensuring the safe use of the medication in patients with hepatic impairment.

Overdosage

In the event of an overdosage, it is imperative to seek immediate medical assistance. Healthcare professionals are advised to contact a Poison Control Center without delay, utilizing the national hotline at 1-800-222-1222 for guidance.

Prompt intervention is crucial in managing potential symptoms associated with overdosage. The specific symptoms may vary depending on the substance involved; therefore, a thorough assessment and appropriate management strategies should be implemented based on clinical presentation and available resources.

Healthcare providers should ensure that they are familiar with the recommended protocols for overdosage management, including supportive care and symptomatic treatment, as necessary. Continuous monitoring of the patient’s condition is essential to address any complications that may arise during the course of treatment.

Nonclinical Toxicology

It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No relevant information is available regarding non-teratogenic effects. Additionally, there is no relevant information provided concerning nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

Postmarketing experience has identified several adverse reactions associated with the use of ibuprofen. Reports include gastrointestinal bleeding, renal impairment, hepatic impairment, anaphylactic reactions, and skin reactions, which encompass serious conditions such as Stevens-Johnson syndrome and toxic epidermal necrolysis. Additionally, cardiovascular events, including heart attack and stroke, have been noted.

Further safety information derived from postmarketing data indicates occurrences of elevated liver enzymes, allergic reactions such as angioedema and urticaria, exacerbation of asthma, and hypertension. The frequency of these adverse reactions remains unknown.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. Patients should be informed not to use this product if they have a history of allergic reactions to ibuprofen or any other pain reliever or fever reducer. It is important to instruct patients to avoid using this medication right before or after heart surgery.

Patients should be made aware of the signs of potential stomach bleeding, including feeling faint, vomiting blood, having bloody or black stools, or experiencing stomach pain that does not improve. They should be instructed to stop use and consult a doctor if they experience any of these symptoms. Additionally, patients should be informed to seek medical advice if they notice symptoms indicative of heart problems or stroke, such as chest pain, trouble breathing, slurred speech, or weakness on one side of the body. They should also be advised to contact a healthcare professional if they experience leg swelling.

Patients should be counseled to discontinue use and consult a doctor if their pain worsens or persists for more than 10 days, if their fever worsens or lasts more than 3 days, or if there is redness or swelling in the painful area. They should also be advised to seek medical attention if any new symptoms arise.

When using this product, patients should be instructed to take it with food or milk if they experience stomach upset. It is essential for patients to consult a doctor before use if they have experienced problems or serious side effects from pain relievers or fever reducers in the past. They should also be advised to seek medical advice if the warning regarding stomach bleeding applies to them or if they have a history of stomach problems, such as heartburn.

Patients with high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or a history of stroke should be encouraged to consult a doctor before using this medication. Additionally, patients taking diuretics or aspirin for heart attack or stroke should be advised to speak with a doctor or pharmacist, as ibuprofen may reduce the effectiveness of aspirin. Finally, patients under a doctor's care for any serious condition or those taking any other medications should be encouraged to consult a healthcare professional before use.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 20-25 ℃ (68-77°F) to ensure its stability and efficacy. Proper storage conditions must be maintained to prevent degradation.

Additional Clinical Information

The route of administration for the medication is oral. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is particularly crucial to avoid ibuprofen after 20 weeks of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery.

Drug Information (PDF)

This file contains official product information for Ibuprofen 200 mg, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)